ELATATUG VEDOTIN
UNII W2SM42UUZ5

Substance Identification & Data

This profile provides standardized clinical and technical data for Elatatug Vedotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) W2SM42UUZ5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3038456-01-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
W2SM42UUZ5
CAS Registry Number
3038456-01-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ELATATUG VEDOTIN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
13747
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Elatatug Vedotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ELATATUG VEDOTIN

Common Names & Synonyms

ELATATUG VEDOTIN [INN]
IMMUNOGLOBULIN G1, ANTI-(HUMAN CLAUDIN 18.2) (HUMAN-MUS MUSCULUS MONOCLONAL TORL-2-307 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL TORL-2-307 .KAPPA.-CHAIN, DIMER, REDUCED, TETRAKIS(THIOETHER) WITH N-(((4-((N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)-L-VALYL-N5-(AMINOCARBONYL)-L-ORNITHYL)AMINO)PHENYL)METHOXY)CARBONYL)-N-METHYL-L-VALYL-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-HYDROXY-1-METHYL-2-PHENYLETHYL)AMINO)-1-METHOXY-2-METHYL-3-OXOPROPYL)-1-PYRROLIDINYL)-2-METHOXY-1-((1S)-1-METHYLPROPYL)-4-OXOBUTYL)-N-METHYL-L-VALINAMIDE
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CLDN18 (CLAUDIN 18, CLAUDIN-18, SURFACTANT ASSOCIATED PROTEIN J, SFTPJ) ISOFORM 2), MONOCLONAL ANTIBODY, CONJUGATED ON AN AVERAGE OF FOUR CYSTEINYL RESIDUES TO VEDOTIN, COMPRISING A CLEAVABLE LINKER AND MONOMETHYLAURISTATIN E (MMAE) (ELATATUG VEDOTIN)